Radiopharmaceutical Manufacturing and Supply (FDG)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract requires the manufacture and supply of Fluorodeoxyglucose F18, a positron emission tomography radiopharmaceutical subject to Nuclear Regulatory Commission licensing and stringent quality control protocols. The supplier must ensure full compliance with all regulatory standards for production, handling, packaging, and transportation, including accurate labeling and integration of barcoded inserts compatible with the Pinestar NMIS system to support traceability and inventory management. Performance is designated for Philadelphia, Pennsylvania, with the product intended for use within the Department of Veterans Affairs healthcare network. The solicitation is classified as a subcontract under NAICS code 325412 and is managed by the 244-NETWORK Contract Office 4 within the Department of Veterans Affairs. The response deadline is August 5, 2026, and the opportunity was posted on July 27, 2026. There is no set-aside designation, and the contract does not specify a point of contact or detailed funding information, but all proposals must demonstrate capability to meet NRC regulatory expectations and technical requirements for FDG production and delivery under the specified conditions and timeline.
General Info
Agency
NAICS
Place of Performance
Philadelphia, PA, 19106, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Veterans Affairs → 244-NETWORK Contract Office 4 (36C244)
Same awarding agency
